Reagan Jarvis
Chief Executive Officer Anocca
Seminars
Wednesday 25th February 2026
Panel Discussion: Leveraging AI & Machine Learning to Accelerate R&D & Construct Design
2:40 pm
- Explore how AI-driven tools are being applied to design next- generation receptor constructs with improved precision and functionality
- Discuss the use of machine learning in identifying novel targets and accelerating preclinical discovery
- Highlight the challenges of obtaining sufficient, high-quality datasets
Thursday 26th February 2026
Non-Viral Gene-Edited Manufacturing to Advance TCR-T Therapies
2:30 pm
- Non-viral gene-edited TCR gene integration for potent TCR-T cell therapies
- Scalable manufacturing inputs to support scale-out and reduce timelines to FIH products
- Enable scalable, cost-effective TCR-T therapy delivery to meet growing clinical demand
Thursday 26th February 2026
Integrating TCR-T Therapies into Existing Standard of Care
9:15 am
- Outline a unique clinical trial design aimed at embedding TCR-T therapies within existing oncology treatment pathways
- Discuss how focused umbrella trial designs accelerate development of TCR-T product libraries
